Recurrent vulvovaginal candidiasis (RVVC) affects millions of women worldwide, severely impairing their quality of life. Despite the existence of multiple induction and maintenance therapeutic strategies, mainly based on antifungals, relapse rates are still high. Palomacare is a vaginal gel containing, among others, hyaluronic acid and , with repairing and moisturizing properties. A series of 5 clinical cases showed that symptoms improved and even disappeared in women with RVVC receiving Palomacare. None of the patients experienced recurrence after the treatment, having their vaginal health restored, suggesting that the non-hormonal , hyaluronic acid and prebiotic-based gel is effective for preventing RVVC relapse in women of reproductive age.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC10026099PMC
http://dx.doi.org/10.1177/11795476231161170DOI Listing

Publication Analysis

Top Keywords

hyaluronic acid
12
acid prebiotic-based
8
vaginal gel
8
recurrent vulvovaginal
8
vulvovaginal candidiasis
8
experience non-hormonal
4
non-hormonal centella
4
centella asiatica
4
asiatica hyaluronic
4
prebiotic-based vaginal
4

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!